Free Trial
TSE:BCT

BriaCell Therapeutics (BCT) Stock Price, News & Analysis

C$5.00 -0.26 (-4.94%)
As of 04/1/2025 03:59 PM Eastern

About BriaCell Therapeutics Stock (TSE:BCT)

Key Stats

Today's Range
C$5.00
C$5.03
50-Day Range
C$0.51
C$8.82
52-Week Range
C$4.33
C$61.20
Volume
5,365 shs
Average Volume
11,294 shs
Market Capitalization
C$12.89 million
P/E Ratio
N/A
Dividend Yield
13.70%
Price Target
N/A
Consensus Rating
N/A

Company Overview

BriaCell Therapeutics Corp. operates as a Phase 3 biotechnology company transforming cancer care with its novel cellular immunotherapies. It is conducting a pivotal Phase 3 clinical trial in advanced breast cancer with its Bria-IMT in combination with an immune check point inhibitor. It is also developing personalized off-the-shelf treatments for breast cancer, prostate cancer, and other cancers. The company has a collaboration with Incyte Corporation to evaluate combination of the Bria-IMT. BriaCell Therapeutics Corp. is based in West Vancouver, Canada.

Remove Ads
Receive BCT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for BriaCell Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

BCT Stock News Headlines

See More Headlines

BCT Stock Analysis - Frequently Asked Questions

BriaCell Therapeutics' stock was trading at C$0.81 at the start of the year. Since then, BCT shares have increased by 517.3% and is now trading at C$5.00.
View the best growth stocks for 2025 here
.

Shares of BCT stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.

Industry, Sector and Symbol

Stock Exchange
TSE
Sector
Medical
Industry
Biotechnology
Sub-Industry
N/A
Current Symbol
TSE:BCT
CIK
N/A
Fax
N/A
Employees
16
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
C$-2,373,845.74
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Book Value
C$0.21 per share
Price / Book
24.28

Miscellaneous

Free Float
N/A
Market Cap
C$12.89 million
Optionable
Not Optionable
Beta
1.83
The 10 Best AI Stocks to Own in 2025 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

This page (TSE:BCT) was last updated on 4/2/2025 by MarketBeat.com Staff
From Our Partners